Everolimus-eluting bioresorbable vascular scaffold
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Everolimus-eluting bioresorbable vascular scaffold, covering 2018-05-18 to 2021-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy [Phase 4]